| MR编号 | ES/V/0337/001 |
|---|
| 药品名称 | Nextmune |
|---|
| 活性成分 | - avian infectious bursal disease virus 0.0 0
|
|---|
| 剂型 | Concentrate and solvent for solution for injection |
|---|
| 上市许可持有人 | Ceva-Phylaxia Veterinary Biologicals Co. Ltd. |
|---|
| 参考成员国 - 产品名称 | Spain (ES) |
|---|
| 互认成员国 - 产品名称 | - Germany (DE)
- Denmark (DK)
- Belgium (BE)
Nextmune - Netherlands (NL)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
- France (FR)
NEXTMUNE SOLUTION ET SOLVANT POUR SUSPENSION INJECTABLE - Portugal (PT)
- Italy (IT)
- Greece (GR)
- Poland (PL)
- Latvia (LV)
Nextmune koncentrāts un šķīdinātājs suspensijas injekcijām pagatavošanai vistām - Lithuania (LT)
Nextmune, koncentratas ir skiediklis injekcinei suspensijai ruošti vištoms - Estonia (EE)
Nextmune - Hungary (HU)
Nextmune vakcina A.U.V. - Bulgaria (BG)
- Cyprus (CY)
- Czechia (CZ)
- Romania (RO)
- Slovakia (SK)
- Slovenia (SI)
- Croatia (HR)
|
|---|
| 许可日期 | 2020/06/03 |
|---|
| 最近更新日期 | 2025/01/03 |
|---|
| 药物ATC编码 | - QI01AD09 avian infectious bursal disease virus (gumboro disease)
| 申请类型 | - TypeLevel1：food
- TypeLevel2：Immunological
- TypeLevel3：Full dossier - art 12.3 Dir 2001/82/EC
- TypeLevel4：[not specified]
- TypeLevel5：[not specified]
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|